Menu Toggle

COVID-19 Genomics UK Consortium

COG-UK is a pioneer in the use of large-scale, rapid whole-genome sequencing of SARS-CoV-2, the virus causing the COVID-19 pandemic, to understand viral transmission and evolution, and to inform public health responses and vaccine development.

Viruses sequenced

News & Twitter

Latest Updates

News

23 Sep 2021

COG-UK’s third Science Showcase – SARS-CoV-2 genomics in action: Thursday 7 October

Join us on Thursday 7 October between 13:00 and 15:30 BST to learn about the role of SARS-CoV-2 genomics in COVID-19 national studies.

Blog

9 Sep 2021

An app for understanding SARS-CoV-2 spike protein mutations

An interactive web-based application has been developed to help explain reports on SARS-CoV-2 mutations and variants generated by COG-UK for a non-expert audience.

Explainer

2 Sep 2021

Explainer: Generation and transmission of inter-lineage recombinants in the SARS-CoV-2 pandemic

For the first time, COG-UK researchers have reported the clear detection and characterisation of recombinant SARS-CoV-2 viruses.

Our Partners

UK-wide genomic sequencing

Our purpose is to provide data that influences public health interventions and policy decisions, and through this make a contribution towards reducing the toll of COVID-19 on our population.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative partnership of NHS organisations, Public Health Agencies, academic partners providing sequencing and analysis capacity, lighthouse labs, and the central sequencing hub of the Wellcome Sanger Institute.